| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.6M | -49.5% |
| Cost of Revenue | $28.8M | -24.8% |
| Gross Profit | -$22.2M | +12.0% |
| R&D Expense | $9.1M | -62.6% |
| SG&A Expense | $42.5M | -23.5% |
| Operating Income | -$73.9M | +29.8% |
| Pre-tax Income | -$101.9M | +17.8% |
| Income Tax | -$117K | -5.9% |
| Net Income | -$101.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.1M | -84.1% |
| Accounts Receivable | $538K | -88.0% |
| Inventory | $41.8M | -7.9% |
| Current Assets | $53.4M | -43.1% |
| Total Assets | $93.8M | -33.8% |
| Current Liabilities | $45.2M | -15.1% |
| Total Liabilities | $49.6M | -15.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$47.6M | +61.3% |
| Capital Expenditures | $4.1M | -78.3% |
| Investing Cash Flow | -$4.1M | +78.3% |
| Financing Cash Flow | $20.5M | -73.9% |
| Free Cash Flow | -$51.7M | +63.5% |
| +17.9% |
| EPS (Basic) | -$51.69 | -8515.0% |
| EPS (Diluted) | -$51.69 | -8515.0% |
| Stockholders' Equity |
| $44.3M |
| -46.7% |